3/28
08:07 am
JSPR
Jasper Therapeutics, Inc. (NASDAQ: JSPR) is now covered by analysts at Royal Bank of Canada. They set an "outperform" rating and a $70.00 price target on the stock.
Low
Report
Jasper Therapeutics, Inc. (NASDAQ: JSPR) is now covered by analysts at Royal Bank of Canada. They set an "outperform" rating and a $70.00 price target on the stock.
3/28
08:07 am
JSPR
Jasper Therapeutics, Inc. (NASDAQ: JSPR) is now covered by analysts at Royal Bank of Canada. They set an "outperform" rating and a $70.00 price target on the stock.
Low
Report
Jasper Therapeutics, Inc. (NASDAQ: JSPR) is now covered by analysts at Royal Bank of Canada. They set an "outperform" rating and a $70.00 price target on the stock.
3/28
04:35 am
JSPR
Rating for JSPR
Low
Report
Rating for JSPR
3/28
04:35 am
JSPR
Rating for JSPR
Low
Report
Rating for JSPR
3/7
08:25 am
JSPR
Jasper Therapeutics, Inc. (NASDAQ: JSPR) had its "outperform" rating re-affirmed by analysts at Oppenheimer Holdings Inc.. They now have a $80.00 price target on the stock.
Low
Report
Jasper Therapeutics, Inc. (NASDAQ: JSPR) had its "outperform" rating re-affirmed by analysts at Oppenheimer Holdings Inc.. They now have a $80.00 price target on the stock.
3/7
08:01 am
JSPR
Rating for JSPR
Low
Report
Rating for JSPR
3/7
08:01 am
JSPR
Rating for JSPR
Low
Report
Rating for JSPR